参考文献/References:
[1] Hall TM,Gordon C,Roy R,et al. Delayed coronary reperfusion is in effective at impeding the dynamic increase in cardiac efferent sympathetic nerve activity following myocardial ischemia[J]. Basic Res Cardiol,2016,111(3):3.
[2] Myat A,Redwood SR,Gersh BJ,et al. Diabetes,incretin hormones and cardioprotection[J]. Heart,2014,100(19):1550-1561.
[3] 陈伟伟,高润霖,刘力生,等.《中国心血管病报告2017》概要[J].中国循环杂志,2018,33(1):1-8.
[4] Liu L,Simon B,Shi J,et al. Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality:evidence on health outcomes and antidiabetic treatment in United States adults[J]. World J Diabetes,2016,7(18):449-461.
[5] Wang Y,Wang W,Wang N,et al. Mitochondrial oxidative stress promotes atherosclerosis and neutrophil extracellular traps in aged mice[J]. Arterioscler Thromb Vasc Biol,2017,37(8):e99-e107.
[6] Kadlec AO,Chabowski DS,Ait-Aissa K,et al. Role of PGC-1α in vascular regulation:implications for atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2016,36(8):1467-1474.
[7] Ping Z,Zhang LF,Cui YJ,et al. The Protective effects of salidroside from exhaustive exercise-induced heart injury by enhancing the PGC-1α-NRF1/NRF2 pathway and mitochondrial respiratory function in rats[J]. Oxid Med Cell Longev,2015,2015:876825.
[8] Thiele RH. Subcellular energetics and metabolism:potential therapeutic applications[J]. Anesth Analg,2017,124(6):1872-1885.
[9] Thangarajah H,Vial IN,Grogan RH,et al. HIF-1αlpha dysfunction in diabetes[J]. Cell Cycle,2010,9(1):75-79.
[10] Bento CF,Pereira P. Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes[J]. Diabetologia,2011,54(8):1946-1956.
[11] Miki T,Itoh T,Sunaga D,et al. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning[J]. Cardiovascular diabetology,2012,11:67.
[12]Drenger B,Ostrovsky IA,Barak M,et al. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart:phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinasemediated inhibition[J]. Anesthesiology,2011,114(6):1364-1372.
[13] Badalzadeh R,Mokhtari B,Yavari R. Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus[J]. ?J Physiol Sci,2015,65(3):201-215.
[14] Cai Z,Luo W,Zhan H,et al. Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart[J]. Proc Natl Acad Sci U S A,2013,110(43):17462-17467.
[15] Yang L,Xie P,Wu J,et al. Sevoflurane postconditioning improves myocardial mitochondrial respiratory function and reduces myocardial ischemia-reperfusion injury by up-regulating HIF-1[J]. Am J Transl Res,2016,8(10):4415-4424.
[16] Yu J,Maimaitili Y,Xie P et al. High glucose concentration abrogates sevoflurane postconditioning cardioprotection by advancing mitochondrial fission but dynamin-related protein 1 inhibitor restores these effects[J]. Acta Physiol (Oxf),2017,220(1):83-98.
[17] Wu J,Yang L,Xie P,et al. Cobalt chloride upregulates impaired HIF-1α expression to restore sevoflurane postconditioning dependent myocardial protection in diabetic rats[J].Front Physiol,2017,8:395.
[18] Xie P,Yang L,Talaiti A,et al. Deferoxamine-activated hypoxia- inducible factor-1 restores cardioprotective effects of sevoflurane postconditioning in diabetic rats[J],Acta Physiol (Oxf),2017,221(2):98-114.
[19] Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease[J]. Annu Rev Physiol,2014,76:39-56.
[20] Alers S,L?ffler AS,Wesselborg S,et al. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy:cross talk,shortcuts,and feedbacks[J]. Mol Cell Biol,2012,32(1):2-11.
[21] Xie Z,He C,Zou MH. AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy[J]. Autophagy,2011,7(10):1254-1255.
[22] Uguccioni G,Hood DA. The importance of PGC-1α in contractile activity-induced mitochondrial adaptations[J]. Am J Physiol Endocrinol Metab,2011,300(2):E361-E371.
[23] Shao D,Liu Y,Liu X,et al. PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERR alpha[J]. Mitochondrion,2010,10(5):516-527.
[24] Venditti P,Bari A,Di Stefano L,et al. Involvement of PGC-1,NRF-1,and NRF-2 in metabolic response by rat liver to hormonal and environmental signals[J]. Mol Cell Endocrinol,2009,305(1-2):22-29.
[25] Zhang Y,Wang C,Jin Y,et al. Activating the PGC-1α/TERT pathway by catalpol ameliorates atherosclerosis via modulating ROS production,DNA damage,and telomere function:implications on mitochondria and telomere link[J]. Oxid Med Cell Longev,2018:2876350.
[26] Song SB,Hwang ES. A Rise in ATP,ROS,and mitochondrial content upon glucose withdrawal correlates with a dysregulated mitochondria turnover mediated by the activation of the protein deacetylase SIRT1[J]. Cells,2018,8(1):11.
[27] Choi GE,Oh JY,Lee HJ,et al. Glucocorticoid-mediated ER-mitochondria contacts reduce AMPA receptor and mitochondria trafficking into cell terminus via microtubule destabilization[J]. Cell Death Dis,2018,9(11):1137.
[28] Hennuyer N,Duplan I,Paquet C,et al. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia,enhances reverse cholesterol transport and decreases inflammation and atherosclerosis[J]. Atherosclerosis,2016,249:200-208.